Neothetics reports it will conduct $20 million at-the-market agreement

Cantor Fitzgerald will sell shares through offering for 3% commission

By Devika Patel

Knoxville, Tenn., Dec. 1 – Neothetics, Inc. negotiated a $20 million at-the-market program with Cantor Fitzgerald & Co. on Dec. 1, according to an 8-K filed Tuesday with the Securities and Exchange Commission.

Cantor will be paid a 3% commission.

The clinical-stage specialty pharmaceutical company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.